Chiusolo, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 5.818
EU - Europa 5.498
AS - Asia 1.174
OC - Oceania 73
AF - Africa 68
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.676
Nazione #
US - Stati Uniti d'America 5.735
DE - Germania 1.977
SE - Svezia 1.015
CN - Cina 817
IT - Italia 771
UA - Ucraina 384
IE - Irlanda 299
FR - Francia 291
GB - Regno Unito 281
FI - Finlandia 123
IN - India 123
PL - Polonia 119
AU - Australia 66
CA - Canada 61
TR - Turchia 59
CI - Costa d'Avorio 54
BE - Belgio 36
NL - Olanda 27
BR - Brasile 25
IR - Iran 24
SG - Singapore 24
RU - Federazione Russa 23
HK - Hong Kong 22
AT - Austria 19
VN - Vietnam 19
ES - Italia 18
JP - Giappone 17
MX - Messico 15
RO - Romania 15
HU - Ungheria 12
ID - Indonesia 12
NO - Norvegia 10
PT - Portogallo 9
CH - Svizzera 8
CZ - Repubblica Ceca 7
GR - Grecia 7
KR - Corea 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
HR - Croazia 6
IL - Israele 6
SA - Arabia Saudita 6
CL - Cile 5
EE - Estonia 5
NP - Nepal 5
RS - Serbia 5
TW - Taiwan 5
BG - Bulgaria 4
BZ - Belize 4
DK - Danimarca 4
EU - Europa 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DZ - Algeria 3
EG - Egitto 3
LB - Libano 3
MD - Moldavia 3
PE - Perù 3
BD - Bangladesh 2
CO - Colombia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
IS - Islanda 2
LI - Liechtenstein 2
MA - Marocco 2
UY - Uruguay 2
AR - Argentina 1
GH - Ghana 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
SC - Seychelles 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 12.676
Città #
Chandler 1.057
Ashburn 442
Dublin 294
Jacksonville 294
Dearborn 243
San Mateo 227
Nanjing 178
Ann Arbor 169
Houston 160
Wilmington 158
Milan 147
Beijing 144
Nürnberg 114
Woodbridge 114
Fairfield 113
Rome 112
Boston 109
New York 109
Redwood City 106
Warsaw 106
Seattle 97
Lancaster 91
Cattolica 89
Nanchang 84
Marseille 81
Princeton 81
Los Angeles 76
Bremen 71
Lawrence 68
Abidjan 54
Florence 53
Redmond 51
Izmir 49
Munich 47
Kunming 46
Chicago 39
Boardman 34
Helsinki 33
Tianjin 33
Brussels 32
Norwalk 32
Cambridge 31
Shanghai 30
Shenyang 30
Guangzhou 29
Pune 29
Leawood 28
Hangzhou 27
Changsha 26
Hefei 26
Mountain View 25
Zhengzhou 25
Hebei 23
Auburn Hills 22
Jiaxing 21
London 19
Brisbane 18
Toronto 18
Washington 18
Hong Kong 17
Hanoi 16
University Park 16
Augusta 15
San Francisco 15
Brooklyn 14
Philadelphia 14
Phoenix 12
San Diego 11
Changchun 10
Falls Church 10
Fremont 10
Lanzhou 10
Vienna 10
Hermosillo 9
Portland 9
Buffalo 8
Simi Valley 8
Amsterdam 7
Arezzo 7
Berlin 7
Canberra 7
Chengdu 7
Edinburgh 7
Fuzhou 7
Jinan 7
Naples 7
San Martino Buon Albergo 7
Singapore 7
Adelaide 6
Andover 6
Atlanta 6
Denver 6
Hyderabad 6
McKinney 6
Melbourne 6
Ottawa 6
Padova 6
Riyadh 6
Sydney 6
Tokyo 6
Totale 6.445
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 1.421
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 344
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 303
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 295
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 221
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 159
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 143
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 139
Correlation between paraproteinaemia and viral reactivation after allo-SCT 131
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 130
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 129
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 129
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 127
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 127
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 126
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 122
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 121
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 119
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 117
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 114
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 111
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 110
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 110
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 108
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 107
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 107
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 107
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 101
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 101
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 101
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 100
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 99
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 99
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 98
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 97
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
Work related acute leukemia and mucor mycosis in a boat-builder 95
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 95
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 93
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 93
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 92
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 92
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 91
Hyperleukocytosis and leukostasis: management of a medical emergency 91
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 91
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 90
Hyperleukocytosis and leukostasis: management of a medical emergency 90
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 88
Neurologic improvement after peripheral blood stem cell transplantation in poems 88
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 88
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 87
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 87
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 86
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 85
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 84
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 83
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 80
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 79
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 79
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 79
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 79
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 76
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 75
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 74
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 74
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 72
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 72
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 70
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 70
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 67
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 66
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 65
Changes in protein serum levels during stem cell transplantation 64
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 63
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 63
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 62
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 62
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 62
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 60
Unrelated cord blood transplantation and post-transplant cyclophosphamide 59
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 59
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 58
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 58
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 58
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 57
Unrelated cord blood transplantation and post-transplant cyclophosphamide 57
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 56
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 56
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 55
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 55
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 54
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 53
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 52
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 52
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 52
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 51
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 51
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 51
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 51
Totale 10.766
Categoria #
all - tutte 44.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019279 0 0 0 0 0 0 0 0 0 70 126 83
2019/20202.111 319 175 173 147 203 236 199 96 122 166 156 119
2020/20211.252 81 116 81 96 111 101 114 32 151 60 265 44
2021/20221.549 150 91 43 70 104 39 35 219 90 127 261 320
2022/20233.213 435 436 243 475 226 378 182 241 316 89 134 58
2023/20241.888 84 450 125 172 150 302 162 115 105 223 0 0
Totale 13.012